GAD65, but not GAD67, is a major autoantigen and autoantibodies to GAD65 are detected at high frequency in patients with newly diagnosed type 1 diabetes (T1D) (∼80%) [4]. This evidence concerns the gene GAD2 and type 1 diabetes mellitus.